Tag: Pakistan

Explore all our news . .

Recent Posts

TBRG Investor News: If You Have Suffered Losses in TruBridge, Inc. (NASDAQ: TBRG), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

NEW YORK, May 13, 2026 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of TruBridge, Inc. (NASDAQ: TBRG) resulting from allegations that TruBridge may have issued materially misleading business information to the investing public. SO

TBRG Investor News: If You Have Suffered Losses in TruBridge, Inc. (NASDAQ: TBRG), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

NEW YORK, May 13, 2026 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of TruBridge, Inc. (NASDAQ: TBRG) resulting from allegations that TruBridge may have issued materially misleading business information to the investing public. SO

FLOW Cryptocurrency Investor News: If You Have Suffered Losses in FLOW Cryptocurrency, You Are Encouraged to Contact The Rosen Law Firm About Your Rights

NEW YORK, May 13, 2026 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of investors in FLOW (FLOW-USD) cryptocurrency, resulting from allegations that Flow Foundation may have issued materially misleading business information to the investing public. SO

ADMA Investor News: If You Have Suffered Losses in ADMA Biologics, Inc. (NASDAQ: ADMA), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

NEW YORK, May 13, 2026 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of ADMA Biologics, Inc. (NASDAQ: ADMA) resulting from allegations that ADMA Biologics may have issued materially misleading business information to the

ADMA Investor News: If You Have Suffered Losses in ADMA Biologics, Inc. (NASDAQ: ADMA), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

NEW YORK, May 13, 2026 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of ADMA Biologics, Inc. (NASDAQ: ADMA) resulting from allegations that ADMA Biologics may have issued materially misleading business information to the

Quest Software Extends Data and AI Leadership with Quest Data Modeler and Quest Data Intelligence, Enhancing its Trusted Data Management Platform

New capabilities deliver cloud-native modeling, AI-powered policy management, and an expanded library of QuestAI assistants, giving modern data teams a single, governed foundation for analytics and AI initiatives — from data structure to data access AUSTIN, Texas, May 13, 2026 (GLOBE NEWSWIRE) — Quest Software, a global leader in data